• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 II ASSAY; FREE THYROXINE RADIOIMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 II ASSAY; FREE THYROXINE RADIOIMMUNOASSAY Back to Search Results
Catalog Number 07027397529
Device Problem Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/09/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).In medwatch field the patient's age was provided as 10 to 20 years old.
 
Event Description
The customer complained of questionable elecsys t3 results for 1 patient sample on a cobas 6000 e 801 module and a cobas 6000 e 601 module.Of the data provided, there were discrepant t3 and elecsys ft4 ii assay results.The e 801 serial (b)(4) the e 601 serial (b)(4).This medwatch will cover the ft4 ii data.Refer to medwatch with (b)(6) for information on the t3 results.The initial t3 result was 422 ng/dl on the e 801.The physician requested a repeat for the t3 result.The repeat t3 result was 423 ng/dl on the e 801.The sample was repeated on an e 601 and the t3 result was 166.6 ng/dl.The initial ft4 ii result was 0.915 ng/dl on the e 801.After the physician requested the repeat of the sample the ft4 result was 0.919 ng/dl on the e801.The sample was repeated on an e 601 and the ft4 ii result was 1.43 ng/dl.No erroneous results were reported outside of the laboratory.There was no allegation of an adverse event.
 
Manufacturer Narrative
The customer provided a sample for investigation.The investigation found the sample contained an interfering factor to a component of the assay.The package insert provides a disclaimer stating in rare cases, interference due to extremely high titers of antibodies to analytic-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.The investigation is ongoing.
 
Manufacturer Narrative
For diagnostic purposes, the results should always be assessed in conjunction with the patient´s medical history, clinical examinations and other findings.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 II ASSAY
Type of Device
FREE THYROXINE RADIOIMMUNOASSAY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7834057
MDR Text Key119492652
Report Number1823260-2018-02929
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 11/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07027397529
Device Lot Number265631
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 08/10/2018
Initial Date FDA Received08/30/2018
Supplement Dates Manufacturer Received08/10/2018
08/10/2018
Supplement Dates FDA Received10/18/2018
11/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-